poisar

Stock

Viking Therapeutics, Inc. VKTX

$33.93-1.32%

Overview

VKTX market data

Price History

VKTX price chart · 1M
O
34.19
H
34.29
L
33.16
C
33.93
Vol
116,168.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$34.19
Previous Close
$34.38
Day High
$34.29
Day Low
$33.16
52 Week High
$42.76
52 Week Low
$27.19
7 Day Return
-1.32%
30 Day Return
+0.25%
90 Day Return
+3.70%
1 Year Return
+8.46%
Daily Notional Volume
$3.9M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$3.19
Diluted earnings per share over the trailing twelve months.
Beta
0.62
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$22.96 – $43.15
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $3.9B · P/B 6.22.

Company News

10 captured
Viking Therapeutics Has $502 Million in Cash and 1 Big Catalyst Left in 2026 -- Is That Enough?The Motley Fool · Aug 27, 2026, 3:15 PM
JP Morgan Maintains Overweight on Viking Therapeutics, Lowers Price Target to $65Benzinga · Aug 11, 2026, 2:50 PM
Viking Therapeutics Declined in July, and why its Long-Term Prospects are UndiminishedThe Motley Fool · Aug 6, 2026, 3:02 PM
Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover TargetThe Motley Fool · Jul 30, 2026, 11:15 PM
Viking Therapeutics Stock Moves Lower: What's Going On?Benzinga · Jul 30, 2026, 5:08 PM
Canaccord Genuity Maintains Buy on Viking Therapeutics, Raises Price Target to $114Benzinga · Jul 30, 2026, 3:56 PM
Viking Therapeutics Q2 EPS $(1.10) Beats $(1.25) EstimateBenzinga · Jul 29, 2026, 8:07 PM
Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law FirmGlobenewswire Inc · Jul 17, 2026, 11:15 AM
Kuehn Law Encourages Investors of Rhythm Pharmaceuticals, Inc. to Contact Law FirmGlobenewswire Inc · Jul 17, 2026, 11:15 AM
Is It Too Late to Buy Eli Lilly?The Motley Fool · Jul 8, 2026, 7:15 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
Viking Therapeutics, Inc. (VKTX) stock — price, valuation & news | Poisar